Obesity, metabolic syndrome, and microbiota: multiple interactions

Area of Science:

• Microbiology
• Metabolic Syndrome
• Obesity Research

Background:

• The human gut harbors a diverse microbial community essential for host functions like digestion.
• Gut microbiota composition significantly impacts host weight and metabolism.
• Obesity is associated with altered gut microbiota, affecting its metabolic functions.

Purpose of the Study:

• To investigate the role of gut microbiota in obesity and metabolic syndrome.
• To explore the transmissibility of obesity-associated microbial traits.
• To understand the influence of diet and innate immunity on the gut microbiome and metabolic health.

Main Methods:

• Conventionalization of germ-free mice with gut microbiota from obese or lean donors.
• Studies on genetically or diet-induced obese mouse models.
• Analysis of gut microbiome composition and metabolic pathways in obese and lean individuals/mice.
• Investigation of Toll-like receptor 5 (TLR5) deficiency effects on metabolism and microbiota.

Main Results:

• Conventionalization with obese-derived microbiota leads to increased body fat and obesity in recipient mice.
• Obese individuals show reduced gut microbial diversity and altered metabolic pathways.
• High-fat diets rapidly modulate gut microbiome composition.
• Mice lacking TLR5 develop obesity and insulin resistance, and their microbiota transmits metabolic syndrome features.

Conclusions:

• The gut microbiota is a key factor in the development of obesity and metabolic syndrome.
• Microbiota composition and function are influenced by host genetics, diet, and immune system.
• Targeting the gut microbiome may offer therapeutic strategies for metabolic disorders.